Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -179.58% is 22% below its 5-year average of -147.52%, around the middle of its 5-year range (-353.53%–-34.93%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.87% above its 12-month average of -190.78%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -179.58%.
RETURN ON INVESTED CAPITAL (ROIC)
-179.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-190.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-198.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-147.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+5.87%
CURRENT VS 3Y AVG
+9.61%
CURRENT VS 5Y AVG
-21.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
-421.50%
vs the sector median at left
Intelligent Bio Solutions Inc.
Market Cap
$5.31M
Return on Invested Capital (ROIC)
-179.58%
TTM Avg
-190.78%
3Y Avg
-198.68%
5Y Avg
-147.52%
Market Cap
$5.37M
Return on Invested Capital (ROIC)
-161.69%
TTM Avg
-192.94%
3Y Avg
-175.58%
5Y Avg
-149.58%
Market Cap
$5.41M
Return on Invested Capital (ROIC)
-160.81%
TTM Avg
-121.99%
3Y Avg
-86.44%
5Y Avg
-69.30%
Market Cap
$5.30M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-67.32%
3Y Avg
-73.33%
5Y Avg
-73.33%
Market Cap
$5.25M
Return on Invested Capital (ROIC)
-156.69%
TTM Avg
-654.50%
3Y Avg
-599.09%
5Y Avg
-420.09%
Market Cap
$5.23M
Return on Invested Capital (ROIC)
-27.41%
TTM Avg
-21.46%
3Y Avg
-17.98%
5Y Avg
-12.44%
Market Cap
$5.18M
Return on Invested Capital (ROIC)
-35.07%
TTM Avg
-9.54%
3Y Avg
2.54%
5Y Avg
2.54%
Market Cap
$5.16M
Return on Invested Capital (ROIC)
-225.12%
TTM Avg
-13.17%
3Y Avg
-9.09%
5Y Avg
-9.09%
Market Cap
$5.61M
Return on Invested Capital (ROIC)
-94.08%
TTM Avg
-1223.16%
3Y Avg
-731.00%
5Y Avg
-532.24%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intelligent Bio Solutions Inc. (INBS) | $5.31M | -179.58% | -190.78% | -198.68% | -147.52% |
| Soligenix, Inc. (SNGX)vs › | $5.37M | -161.69% | -192.94% | -175.58% | -149.58% |
| Pulmatrix, Inc. (PULM)vs › | $5.41M | -160.81% | -121.99% | -86.44% | -69.30% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.30M | N/A | -67.32% | -73.33% | -73.33% |
| Alzamend Neuro Inc (ALZN)vs › | $5.25M | -156.69% | -654.50% | -599.09% | -420.09% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | -27.41% | -21.46% | -17.98% | -12.44% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.18M | -35.07% | -9.54% | 2.54% | 2.54% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.16M | -225.12% | -13.17% | -9.09% | -9.09% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.61M | -94.08% | -1223.16% | -731.00% | -532.24% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.70M | -84.15% | -84.15% | -84.15% | -84.15% |
ROIC
-179.6%
ROE
-225.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -179.58% |
| 2026-03-31 | -114.61% |
| 2025-12-31 | -90.67% |
| 2025-09-30 | -215.49% |
| 2025-06-30 | -353.53% |
| 2025-03-31 | -198.17% |
| 2024-12-31 | -232.17% |
| 2024-09-30 | -119.96% |
| 2024-06-30 | -112.78% |
| 2024-03-31 | -86.75% |
| 2023-12-31 | -342.28% |
| 2023-09-30 | -287.72% |
| 2023-06-30 | -249.07% |
| 2023-03-31 | -88.36% |
| 2022-12-31 | -49.42% |
| 2022-09-30 | -105.55% |
| 2022-06-30 | -83.98% |
| 2022-03-31 | -63.26% |
| 2021-12-31 | -54.68% |
| 2021-09-30 | -34.93% |
| 2021-06-30 | -35.07% |
| 2021-03-31 | -27.82% |
| 2020-12-31 | -11.27% |
| 2020-09-30 | -138.20% |
| 2019-09-30 | -422.40% |
| 2019-06-30 | -556.14% |
| 2019-03-31 | -480.03% |
| 2018-06-30 | -278.41% |
